Companies
Employees1-10
Funding$5.7M
Valuation$1.4M
Revenue$427,775
Healthcare AIAI ApplicationAPI / PlatformSeed$1M-$10M
About
Raina Biosciences develops GEMORNA, a generative AI platform used to design and optimize mRNA sequences for therapeutics. Targeting biopharma and biotech companies, the company leverages AI and high-throughput experimental validation to improve mRNA translational capacity, stability, and potency. They operate as a spin-out from MIT, focusing on accelerating drug discovery timelines for novel mRNA applications.
Active Roles
0No active roles right now.
Get notified when they postKey Investors
The available sources do not contain the names of specific investors, only that the company received angel backing.